Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-12

Clinical Trial Update: A Clinical Trial to Evaluate the Efficacy and Safety of HL301 Versus Umkamin Tab in Acute Bronchitis Patients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing HL301 to Umkamin Tab in acute bronchitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HL301
  • Umkamin Tab

Snippet

Sponsor: Hanlim Pharm. Co., Ltd. | Conditions: Acute Bronchitis | Phase 3 | Status: COMPLETED